CRISPR Therapeutics AG (CRSP)
56.95
-1.23
(-2.11%)
USD |
NASDAQ |
Dec 05, 12:39
CRISPR Therapeutics Shareholders Equity (Quarterly): 1.916B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 17.32B |
| Intellia Therapeutics, Inc. | 748.42M |
| Novartis AG | 44.33B |
| Beam Therapeutics, Inc. | 966.00M |
| BeOne Medicines Ltd. | 4.129B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.245B |
| Total Liabilities (Quarterly) | 329.33M |
| Debt to Equity Ratio | 0.1101 |
| Current Ratio | 16.22 |
| Net Debt Paydown Yield | 0.07% |